FDA Approves First Rapid-Acting Insulin Biosimilar Product for Treatment of Diabetes
Today, the U.S. Food and Drug Administration approved Merilog (insulin-aspart-szjj) as biosimilar to Novolog (insulin aspart) for the improvement of glycemic control in adults and pediatric patients ...
FDA approves first rapid-acting insulin
According to the FDA, the medication quickly helps to lower mealtime blood sugar spikes to improve control of blood sugar in ...
The Financial Express8h
FDA gives nod to first rapid-acting insulin biosimilar for diabetes treatment
The U.S. Food and Drug Administration (USFDA) on Friday approved Merilog as biosimilar to Novolog (insulin aspart) for the ...
FDA approves Sanofi biosimilar product for treatment of diabetes
The U.S. Food and Drug Administration approved Merilog as biosimilar to Novolog for the improvement of glycemic control in adults and pediatric ...
Le Lézard5d
Pen Needles Market to Hit USD 3.08 Billion by 2030 with 9.2% CAGR | MarketsandMarketstm
The pen needles market valued at US$ 1.69 Billion in 2023, is forecasted to grow at a robust CAGR of 9.2%, reaching US$ 1.81 Billion in 2024 and an impressive US$ 3.08 Billion by 2030. The pen needles ...
Medscape6d
A Review of 20 Years' Experience With the Novopen Family of Insulin Injection Devices
NovoPen ®, the first insulin pen injector, was introduced in 1985 ... The published evidence identified also showed that insulin administration via NovoPen ® devices was for most patients ...
Does Medicare Cover Ozempic?
Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...
PharmiWeb3d
Diabetes Drugs Market Forecasted to Reach US$ 177.74 Billion by 2034, Expanding at a CAGR of 7.7%
The global Diabetes Drugs Market size was valued at USD 84.65 billion in 2024 and is expected to be worth around USD 177.74 ...
Orange County Business Journal4d
Beta Bionics Debuts at Nearly $1B Value
Beta Bionics’ IPO marks one of the largest public offerings for an Orange County-based company in over three years, second ...
Half of adults with Type 1 diabetes say condition limits spontaneity
A recent survey found that more than half of adults living with Type 1 diabetes believe the condition limits their ability to be spontaneous ...
Opinion
Editorial: Boost state Medicaid funding for long-term care
Concerned for not losing ground over recent advances, the association and others concerned with elder care are asking state legislators to adopt an increase in the state’s share of Medicaid funding — ...
West Pharmaceutical's Long-Term Growth Intact, but Margin Expansion Less Uncertain
West Pharma’s financial strength is solid, and the firm has historically managed a very strong balance sheet. As of year-end 2023, West had total debt outstanding of $206 million. West has ...